79155398 - DBV TECHNOLOGIES

Information

• Trademark
• 79155398

• Source

• Serial Number

  79155398

• Registration Number

  4750180

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  July 18, 2014
  10 years ago

• Registration Date

  June 09, 2015
  9 years ago

• Transaction Date

  July 13, 2024
  5 months ago

• Status Date

  December 24, 2021
  2 years ago

• Published for Opposition Date

  March 24, 2015
  9 years ago

• Location Date

  June 09, 2015
  9 years ago

• Status Code

  709

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  CROWLEY, PAUL

• Attorney Name

  James R. Menker

  Law Office Assigned Location Code

  M30

• Owners

  • DBV TECHNOLOGIES SA

Case File Statements

• DM0000: The mark consists of letters "DBV" above the word "TECHNOLOGIES" all in stylized lettering and below a design comprised of two concentric circles above a wavy line. The color blue appears in the word "TECHNOLOGIES" and the color gray appears in the letter "DBV" and in the two concentric circles and the wavy line.
• GS0051: Medicated adhesive devices in the nature of epicutaneous patches for enabling cutaneous or epicutaneous administration of medicated or pharmaceutical substances in powder form for humans and animals for the treatment of allergies, inflammatory and autoimmune diseases; epicutaneous patches featuring a preparation in powder form for medical purposes for the treatment of allergies, inflammatory and autoimmune diseases; medicated occlusion patches in the nature of epicutaneous patches for enabling the absorption of a medicated substance in powder form via the skin for the treatment of allergies, inflammatory and autoimmune diseases
• CC0000: The color(s) blue and gray is/are claimed as a feature of the mark.
• GS0441: Medical services that use a desensitization method that uses immunotherapy; medical treatments of allergies and inflammatory and autoimmune diseases via administration of allergens, antigens using a patch to be affixed to the unbroken skin of the patient, thus avoiding the allergen being transferred into the blood; medical treatments of allergies and inflammatory and autoimmune diseases that use the epicutaneous method of desensitization via immunotherapy; epicutaneous medical treatments of allergies and inflammatory and autoimmune diseases without prior preparation of the skin other than for simple, light cleansing to keep the cellular structure of the epidermis intact; medical consultancy in the field of desensitization to allergies relating to desensitization to combat allergies
• DS0000: "TECHNOLOGIES"
• GS0101: Medical apparatus, instruments and devices, namely, epicutaneous patches for the cutaneous or epicutaneous administration of substances of medicated or cosmetic substances in powder form for humans or animals sold without medication; occlusion patch dispensers for medical purposes; medical instruments using the electrostatic properties of a biocompatible support, namely, epicutaneous patches sold without medication
• GS0421: Medical and scientific research in the field of immunotherapy, namely, designing scientific methods for epicutaneous immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; scientific research in the field of treating and caring for allergies; scientific research in the field of allergy treatment for a treatment to be applied repeatedly to the skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact and thus avoiding the passage of the allergen into the blood; discovery and development of allergen drugs; medical and scientific research, namely, designing methods for treating allergies via the combination of allergens with immune cells in the skin; medical and scientific research, namely, designing methods for treating allergies via the application of a patch to the unbroken skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact

Case File Event Statements

• 12/5/2014 - 10 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 11/27/2014 - 10 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 12/1/2014 - 10 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/1/2014 - 10 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 12/4/2014 - 10 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/5/2014 - 10 years ago

  5 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 12/9/2014 - 10 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 1/21/2015 - 9 years ago

  16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/9/2014 - 10 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 12/22/2014 - 10 years ago

  9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/22/2014 - 10 years ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/22/2014 - 10 years ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/27/2014 - 9 years ago

  12 - REFUSAL PROCESSED BY IB Type: RFNT

• 1/12/2015 - 9 years ago

  13 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/13/2015 - 9 years ago

  14 - NON-FINAL ACTION MAILED Type: CNRT

• 1/21/2015 - 9 years ago

  15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/22/2015 - 9 years ago

  17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/18/2015 - 9 years ago

  23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 6/9/2015 - 9 years ago

  26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/27/2015 - 9 years ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/13/2015 - 9 years ago

  19 - ASSIGNED TO LIE Type: ALIE

• 2/19/2015 - 9 years ago

  20 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 3/4/2015 - 9 years ago

  21 - NOTICE OF PUBLICATION Type: NPUB

• 3/18/2015 - 9 years ago

  22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 3/24/2015 - 9 years ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/4/2015 - 9 years ago

  25 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 12/24/2021 - 2 years ago

  33 - CANCELLED SECTION 71 Type: C71T

• 9/9/2015 - 9 years ago

  27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 9/30/2015 - 9 years ago

  28 - FINAL DISPOSITION PROCESSED Type: FIMP

• 9/30/2015 - 9 years ago

  29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 10/30/2015 - 9 years ago

  30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 5/4/2017 - 7 years ago

  31 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 11/1/2021 - 3 years ago

  32 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 9/26/2022 - 2 years ago

  35 - INVALIDATION PROCESSED Type: INPC

• 8/24/2022 - 2 years ago

  34 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 9/26/2022 - 2 years ago

  36 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS

• 7/13/2024 - 5 months ago

  39 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 6/15/2024 - 6 months ago

  38 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 10/25/2022 - 2 years ago

  37 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT